PMV Pharmaceuticals PMVP
NASDAQ PMVP
$1.25 -0.01 (-0.79%)
As of: Nov 12, 2026 · 9:30 AM EST

PMV Pharmaceuticals (PMVP) Return on Capital Employed [ROCE] (2020 - 2026)

Updated

PMV Pharmaceuticals (PMVP) posted Return on Capital Employed [ROCE] of -101.16% for Q2 2026, down 40.22 percentage points from -60.95% a year earlier and down 15.77 percentage points from the prior quarter.

Analysis

PMV Pharmaceuticals (PMVP) Return on Capital Employed [ROCE] (2020 - 2026) Analysis & Trends

For FY2025, PMV Pharmaceuticals' Return on Capital Employed [ROCE] came in at -60.49%, down 19.28 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has declined for five consecutive years, with a five-year change of -45.16 percentage points (FY2020 to FY2025).
  • In prior years, PMV Pharmaceuticals' Return on Capital Employed [ROCE] was -41.21% in FY2024 (-8.79 pp), -32.42% in FY2023 (-5.86 pp), -26.56% in FY2022 (-9.22 pp) and -17.33% in FY2021 (-2.00 pp).
  • The Q2 2026 figure stands as the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q4 2020.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has declined in each of the last eight quarters, with an average year-over-year change of -24.78 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q2 2024, with a gain of 0.65 percentage points; the weakest was Q2 2026, with a drop of 40.22 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -85.40% (Q1 2026), -75.76% (Q4 2025) and -70.31% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 PMV Pharmaceuticals 80.80 Mn -307.68 Mn - -89.72%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -89.72%
Jun 30, 2026 -101.16%
Mar 31, 2026 -85.40%
Dec 31, 2025 -75.76%
Sep 30, 2025 -70.31%
Jun 30, 2025 -60.95%
Mar 31, 2025 -51.87%
Dec 31, 2024 -44.27%
Sep 30, 2024 -36.50%
Jun 30, 2024 -34.06%
Mar 31, 2024 -33.07%
Dec 31, 2023 -33.04%
Sep 30, 2023 -34.20%
Jun 30, 2023 -34.71%
Mar 31, 2023 -31.76%
Dec 31, 2022 -28.87%
Sep 30, 2022 -26.45%
Jun 30, 2022 -23.64%
Mar 31, 2022 -20.94%
Dec 31, 2021 -17.90%
API Access

PMV Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=PMVP&period=max&api_key=YOUR_API_KEY